{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal Cartistem",
            "NStudiesAvail": 430108,
            "NStudiesFound": 6,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 6,
            "FieldList": [
                  "OutcomeClassDenomCountGroupId",
                  "OutcomeClassDenomCountValue",
                  "OutcomeClassDenomUnits",
                  "OutcomeClassTitle",
                  "OutcomeDenomCountGroupId",
                  "OutcomeDenomCountValue",
                  "OutcomeDenomUnits",
                  "OutcomeGroupDescription",
                  "OutcomeGroupId",
                  "OutcomeGroupTitle",
                  "OutcomeMeasureAnticipatedPostingDate",
                  "OutcomeMeasureCalculatePct",
                  "OutcomeMeasureDenomUnitsSelected",
                  "OutcomeMeasureDescription",
                  "OutcomeMeasureDispersionType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02338375"
                        ]
                  },
                  {
                        "Rank": 2,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [
                              "12 MONTHS",
                              "24 MONTHS",
                              "12 MONTHS",
                              "24 MONTHS",
                              "ADL (24 MONTHS)",
                              "PAIN (24 MONTHS)",
                              "QOL (24 MONTHS)",
                              "SPORTS (24 MONTHS)",
                              "SYMPTOM (24 MONTHS)"
                        ],
                        "OutcomeDenomCountGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeDenomCountValue": [
                              "6",
                              "6",
                              "6",
                              "6",
                              "6",
                              "6",
                              "6",
                              "6",
                              "6",
                              "6"
                        ],
                        "OutcomeDenomUnits": [
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants",
                              "Participants"
                        ],
                        "OutcomeGroupDescription": [
                              "Drug name and ingredients: CARTISTEM [allogeneic-unrelated, umbilical cord blood-derived mesenchymal stem cells, ex vivo cultured, combined with sodium hyaluronate] Dosage: Administer 0.5 mL of the combination product per cm^2 of the cartilage defect\n\nCartilage defect size range: 2 to 5 cm2 (Dose A)\n\nCARTISTEM\u00ae",
                              "Drug name and ingredients: CARTISTEM [allogeneic-unrelated, umbilical cord blood-derived mesenchymal stem cells, ex vivo cultured, combined with sodium hyaluronate] Dosage: Administer 0.5 mL of the combination product per cm^2 of the cartilage defect\n\nCartilage defect size range: above 5 cm2 (Dose B)\n\nCARTISTEM\u00ae",
                              "Drug name and ingredients: CARTISTEM [allogeneic-unrelated, umbilical cord blood-derived mesenchymal stem cells, ex vivo cultured, combined with sodium hyaluronate] Dosage: Administer 0.5 mL of the combination product per cm^2 of the cartilage defect\n\nCartilage defect size range: 2 to 5 cm2 (Dose A)\n\nCARTISTEM\u00ae",
                              "Drug name and ingredients: CARTISTEM [allogeneic-unrelated, umbilical cord blood-derived mesenchymal stem cells, ex vivo cultured, combined with sodium hyaluronate] Dosage: Administer 0.5 mL of the combination product per cm^2 of the cartilage defect\n\nCartilage defect size range: above 5 cm2 (Dose B)\n\nCARTISTEM\u00ae",
                              "Drug name and ingredients: CARTISTEM [allogeneic-unrelated, umbilical cord blood-derived mesenchymal stem cells, ex vivo cultured, combined with sodium hyaluronate] Dosage: Administer 0.5 mL of the combination product per cm^2 of the cartilage defect\n\nCartilage defect size range: 2 to 5 cm2 (Dose A)\n\nCARTISTEM\u00ae",
                              "Drug name and ingredients: CARTISTEM [allogeneic-unrelated, umbilical cord blood-derived mesenchymal stem cells, ex vivo cultured, combined with sodium hyaluronate] Dosage: Administer 0.5 mL of the combination product per cm^2 of the cartilage defect\n\nCartilage defect size range: above 5 cm2 (Dose B)\n\nCARTISTEM\u00ae",
                              "Drug name and ingredients: CARTISTEM [allogeneic-unrelated, umbilical cord blood-derived mesenchymal stem cells, ex vivo cultured, combined with sodium hyaluronate] Dosage: Administer 0.5 mL of the combination product per cm^2 of the cartilage defect\n\nCartilage defect size range: 2 to 5 cm2 (Dose A)\n\nCARTISTEM\u00ae",
                              "Drug name and ingredients: CARTISTEM [allogeneic-unrelated, umbilical cord blood-derived mesenchymal stem cells, ex vivo cultured, combined with sodium hyaluronate] Dosage: Administer 0.5 mL of the combination product per cm^2 of the cartilage defect\n\nCartilage defect size range: above 5 cm2 (Dose B)\n\nCARTISTEM\u00ae",
                              "Drug name and ingredients: CARTISTEM [allogeneic-unrelated, umbilical cord blood-derived mesenchymal stem cells, ex vivo cultured, combined with sodium hyaluronate] Dosage: Administer 0.5 mL of the combination product per cm^2 of the cartilage defect\n\nCartilage defect size range: 2 to 5 cm2 (Dose A)\n\nCARTISTEM\u00ae",
                              "Drug name and ingredients: CARTISTEM [allogeneic-unrelated, umbilical cord blood-derived mesenchymal stem cells, ex vivo cultured, combined with sodium hyaluronate] Dosage: Administer 0.5 mL of the combination product per cm^2 of the cartilage defect\n\nCartilage defect size range: above 5 cm2 (Dose B)\n\nCARTISTEM\u00ae"
                        ],
                        "OutcomeGroupId": [
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001",
                              "OG000",
                              "OG001"
                        ],
                        "OutcomeGroupTitle": [
                              "Dose A Cohort",
                              "Dose B Cohort",
                              "Dose A Cohort",
                              "Dose B Cohort",
                              "Dose A Cohort",
                              "Dose B Cohort",
                              "Dose A Cohort",
                              "Dose B Cohort",
                              "Dose A Cohort",
                              "Dose B Cohort"
                        ],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [
                              "Subjects underwent a self-assessment of knee function using the IKDC (International Knee Documentation Committee Assessment)subjective knee evaluation before and after the administration of the IP. The assessment is designed to detect improvement or deterioration in symptoms, function, and sports activities due to knee impairment. The possible score ranges from 0 to 100, where 100 = no limitation with daily or sporting activities and the absence of symptoms.\n\nThe IKDC assessment was performed before IP administration and at Months 12 after IP administration in an exploratory fashion. The IKDC score from the Month 12 visit was used as a primary indicator of the post operative change.\n\nThe outcome was presented with the post-operative change amount from the baseline.",
                              "Subjects underwent a self-assessment of joint pain using the 100-mm VAS (Visual Analogue Scale) before and at Months 12 and 24 after IP (investigational product) administration. Higher values represent worse joint pain. Use of NSAIDs and any other analgesics had to be discontinued for 48 hours and 24 hours, respectively, prior to the 100 mm VAS evaluation. The outcome was presented with the post-operative change amount at Months 12 and 24 from the baseline.\n\n100-mm VAS scores range from 0 to 100. Higher values represent worse joint pain.",
                              "The Lysholm knee scoring scale is a self-assessment that rates the severity of common complaints related to knee problems, such as pain, swelling, abnormal sensations, and ability to squat or climb stairs. The possible score ranges from 0 to 100, where 100 = no symptoms or disability. Scores are categorized as excellent (95 to 100), good (84 to 94), fair (65 to 83), and poor (\u226464). Subjects underwent a self-assessment of knee function using the Lysholm score before IP administration and at Months 12 and 24 after IP administration. The outcome was presented with the post-operative change amount at Months 12 and 24 from the baseline.",
                              "The Knee Injury and Osteoarthritis Outcome score (KOOS) knee survey is a self assessment of knee function and knee-related quality of life (QOL). Subjects responded to each question regarding knee-related symptoms, swelling, pain, impaired function, or changes in QOL with 1 of 5 possible answers that range from \"never/not at all\" to \"always/extremely.\" The possible score for each parameter ranges from 0 to 100, where 0=extreme problems and 100=no problems. Subjects completed the KOOS knee survey before IP (investigational product) administration and at Month 24 after IP administration. The outcome was presented with the post-operative change amount at Month 24 from the baseline.",
                              "Subjects underwent a self-assessment of knee function using the IKDC subjective knee evaluation before and after the administration of the IP. The assessment is designed to detect improvement or deterioration in symptoms, function, and sports activities due to knee impairment. The possible score ranges from 0 to 100, where 100 = no limitation with daily or sporting activities and the absence of symptoms. The IKDC assessment was performed before IP administration and at Month 24 after IP administration in an exploratory fashion. The outcome was presented with the post-operative change amount at Month 24 from the baseline."
                        ],
                        "OutcomeMeasureDispersionType": [
                              "Standard Deviation",
                              "Standard Deviation",
                              "Standard Deviation",
                              "Standard Deviation",
                              "Standard Deviation"
                        ],
                        "NCTId": [
                              "NCT01733186"
                        ]
                  },
                  {
                        "Rank": 3,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01041001"
                        ]
                  },
                  {
                        "Rank": 4,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT01626677"
                        ]
                  },
                  {
                        "Rank": 5,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT02755376"
                        ]
                  },
                  {
                        "Rank": 6,
                        "OutcomeClassDenomCountGroupId": [],
                        "OutcomeClassDenomCountValue": [],
                        "OutcomeClassDenomUnits": [],
                        "OutcomeClassTitle": [],
                        "OutcomeDenomCountGroupId": [],
                        "OutcomeDenomCountValue": [],
                        "OutcomeDenomUnits": [],
                        "OutcomeGroupDescription": [],
                        "OutcomeGroupId": [],
                        "OutcomeGroupTitle": [],
                        "OutcomeMeasureAnticipatedPostingDate": [],
                        "OutcomeMeasureCalculatePct": [],
                        "OutcomeMeasureDenomUnitsSelected": [],
                        "OutcomeMeasureDescription": [],
                        "OutcomeMeasureDispersionType": [],
                        "NCTId": [
                              "NCT04310215"
                        ]
                  }
            ]
      }
}